Achaogen's antibiotic gets FDA nod for urinary tract infections

(Reuters) - Achaogen Inc said on Tuesday U.S. health regulators cleared its antibiotic to treat adults with complicated urinary tract infections, but declined approval for treating bloodstream infections.